LAMPROPOULOS FRED P
Known title: PRESIDENT AND CEOCIK: 0000901534
Associated companies
Transaction History
| MMSI | ▼ Sell | Open Market | 10,000 | $880K | 11/25/2025 | View on chart |
| MMSI | ▼ Sell | Open Market | 25,000 | $2.2M | 11/21/2025 | View on chart |
| MMSI | ▼ Sell | Open Market | 20,000 | $1.7M | 11/20/2025 | View on chart |
| MMSI | ▼ Sell | Open Market | 5,000 | $424K | 11/18/2025 | View on chart |
| MMSI | ▲ Buy | Option Exercise | 159,151 | $8.9M | 8/29/2025 | View on chart |
| MMSI | ▼ Sell | Tax Withholding | 124,824 | $11.3M | 8/29/2025 | View on chart |
| MMSI | ▲ Buy | Option Exercise | 2,000 | $111K | 8/29/2025 | View on chart |
| MMSI | ▼ Sell | Tax Withholding | 1,454 | $132K | 8/29/2025 | View on chart |
| MMSI | ▼ Sell | Open Market | 400 | $38K | 6/10/2025 | View on chart |
| MMSI | ▼ Sell | Open Market | 10,000 | $952K | 6/5/2025 | View on chart |
| MMSI | ▼ Sell | Open Market | 10,000 | $951K | 5/30/2025 | View on chart |
| MMSI | ▼ Sell | Open Market | 20,000 | $1.9M | 5/27/2025 | View on chart |
| MMSI | ▼ Sell | Open Market | 11,320 | $1.2M | 3/5/2025 | View on chart |
| MMSI | ▼ Sell | Open Market | 20,000 | $2.1M | 3/5/2025 | View on chart |
| MMSI | ▼ Sell | Open Market | 410 | $43K | 3/5/2025 | View on chart |
| MMSI | ▼ Sell | Open Market | 2,590 | $269K | 3/5/2025 | View on chart |
| MMSI | ▼ Sell | Tax Withholding | 26,043 | $2.7M | 2/28/2025 | View on chart |
| MMSI | ▲ Buy | Option Exercise | 4,000 | $179K | 2/28/2025 | View on chart |
| MMSI | ▼ Sell | Tax Withholding | 2,494 | $254K | 2/28/2025 | View on chart |
| MMSI | ▲ Buy | Grant | 20,384 | $0 | 2/28/2025 | View on chart |
| MMSI | ▲ Buy | Option Exercise | 38,002 | $1.7M | 2/28/2025 | View on chart |
| MMSI | ▲ Buy | Grant | 30,755 | $0 | 2/27/2025 | View on chart |
| MMSI | ▼ Sell | Tax Withholding | 13,501 | $1.3M | 2/27/2025 | View on chart |
| MMSI | ▲ Buy | Grant | 24,572 | $0 | 3/4/2024 | View on chart |
| MMSI | ▲ Buy | Grant | 18,962 | $0 | 3/4/2024 | View on chart |
| MMSI | ▼ Sell | Tax Withholding | 8,343 | $638K | 3/4/2024 | View on chart |
| MMSI | ▲ Buy | Option Exercise | 200,000 | $5.6M | 8/25/2023 | View on chart |
| MMSI | ▲ Buy | Option Exercise | 6,000 | $169K | 8/25/2023 | View on chart |
| MMSI | ▼ Sell | Tax Withholding | 135,356 | $9.1M | 8/25/2023 | View on chart |
| MMSI | ▼ Sell | Tax Withholding | 3,660 | $246K | 8/25/2023 | View on chart |
| MMSI | ▼ Sell | Open Market | 5,278 | $357K | 3/14/2023 | View on chart |
| MMSI | ▼ Sell | Open Market | 19,699 | $1.3M | 3/14/2023 | View on chart |
| MMSI | ▼ Sell | Open Market | 19,176 | $1.3M | 3/2/2023 | View on chart |
| MMSI | ▼ Sell | Open Market | 1,483 | $104K | 3/1/2023 | View on chart |
| MMSI | ▲ Buy | Grant | 27,159 | $0 | 2/28/2023 | View on chart |
| MMSI | ▼ Sell | Tax Withholding | 12,030 | $849K | 2/28/2023 | View on chart |
| MMSI | ▲ Buy | Option Exercise | 50,000 | $803K | 8/10/2022 | View on chart |
| MMSI | ▲ Buy | Option Exercise | 6,000 | $96K | 8/10/2022 | View on chart |
| MMSI | ▼ Sell | Tax Withholding | 29,341 | $1.8M | 8/10/2022 | View on chart |
| MMSI | ▼ Sell | Tax Withholding | 2,971 | $185K | 8/10/2022 | View on chart |
| MMSI | ▼ Sell | Tax Withholding | 7,832 | $509K | 2/28/2022 | View on chart |
| MMSI | ▲ Buy | Grant | 17,680 | $0 | 2/26/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Merit Medical Systems sets Q3 2026 earnings date
Merit Medical Systems announced it will report its third-quarter 2026 results on October 29, 2026. This upcoming earnings date is the primary catalyst for the stock, as investors await fresh financial updates. The company is currently trading within its 52-week range, with an average analyst target price of $101.45.
Merit Medical Systems sets Q3 2026 earnings date. Merit Medical Systems announced it will report its third-quarter 2026 results on October 29, 2026. This upcoming earnings date is the primary catalyst for the stock, as investors await fresh financial updates. The company is currently trading within its 52-week range, with an average analyst target price of $101.45.